In Anaheim, Medicaid providers billed at least $728,943 in 2024 for services under HCPCS codes tied to COVID-19, according to data from the U.S. Department of Health and Human Services Medicaid Provider Spending database. This figure marked a 0.9% rise from 2023, which saw $722,661 in claims for the same COVID-related codes.
Medicaid, administered by each state with both federal and state funding, serves low-income families and individuals including children, seniors and those with disabilities, making it one of the largest components of the U.S. health care system.
With Medicaid payments sourced from taxpayers, shifts in local spending reflect the allocation of public health care funds in a given area.
This analysis identifies COVID-19–related services exclusively through HCPCS codes expressly labeled as “COVID-19” or “coronavirus” in billing notes or data references. Therefore, the reported totals reflect only services coded specifically for COVID and do not account for other pandemic-associated care billed under non-specific codes.
For context, San Jose reported the highest Medicaid payments in California for COVID-19 services in 2024, totaling $5,601,479 in related claims.
In Anaheim, 10 providers filed Medicaid claims for COVID-19–related care in 2024. COVID-19 Vaccine Administration was among the most significant codes, amounting to $603,215.
On average, Anaheim providers received $72,894 each in Medicaid payments for COVID-19 services, surpassing the statewide average of $52,976 per provider.
Medicaid payments for all other billing categories rose by $55,789,006 from 2020 to 2024, which is a 53.6% increase.
The Centers for Medicare & Medicaid Services reported combined state and federal Medicaid spending of about $871.7 billion in the 2023 fiscal year, representing around 18% of national health expenses, up from $613.5 billion in 2019, prior to the COVID-19 pandemic.
This increase amounts to roughly 40% growth over a few years, mainly due to increased enrollment and higher service use during and following the pandemic.
Recent federal budget measures under the Trump administration include major proposals to trim federal Medicaid funds and alter the program’s structure. The “One Big Beautiful Bill Act,” enacted in 2025, is expected to reduce federal Medicaid spending by over $1 trillion over the next decade, with changes such as added work requirements and more cost-sharing, potentially decreasing coverage and funding for select beneficiaries. These adjustments are anticipated to shift more fiscal responsibility to states and slow federal Medicaid growth, even as the program continues to serve millions nationwide.
| Year | COVID-19–Related Payments | COVID-19 Payments % Change (YoY) | Total Medicaid Payments |
|---|---|---|---|
| 2024 | $728,943 | 0.9% | $160,528,366 |
| 2023 | $722,661 | -55.9% | $125,150,029 |
| 2022 | $1,637,423 | -31.7% | $92,413,186 |
| 2021 | $2,397,932 | 580.9% | $90,980,568 |
| 2020 | $352,149 | N/A | $104,362,566 |
| 2019 | $0 | N/A | $110,459,365 |
| 2018 | $0 | N/A | $79,797,748 |
| HCPCS Code | Description | Medicaid Payments | Claims |
|---|---|---|---|
| 90480 | COVID-19 Vaccine Administration | $603,215 | 12,959 |
| 87811 | Immunoassay | $120,956 | 8,481 |
| U0002 | COVID Specific | $4,772 | 93 |
Note: This total includes only HCPCS codes explicitly designated for COVID-19 services; it does not capture all types of pandemic-related care spending.
Information in this story comes from the U.S. Department of Health and Human Services Medicaid Provider Spending database. Source data is available here.


